Dupilumab reduces OCS use and improves lung function in patients with severe OCS-dependent asthma

Gurnell, MarkDomingo, ChristianRabe, Klaus FMenzies-Gow, AndrewPrice, DavidBrusselle, GuyWechsler, Michael EXia, ChangmingPandit-Abid, NamiGall, RebeccaJacob-Nara, Juby A.Rowe, Paul J.Deniz, YamoSiddiqui, Shahid2023-11-302023-11-302022Gurnell, M, Domingo, C, Rabe, K F, Menzies-Gow, A, Price, D, Brusselle, G, Wechsler, M E, Xia, C, Pandit-Abid, N, Gall, R, Jacob-Nara, J A, Rowe, P J, Deniz, Y & Siddiqui, S 2022, 'Dupilumab reduces OCS use and improves lung function in patients with severe OCS-dependent asthma', European Respiratory Journal, vol. 60, no. Suppl. 66, 3620. https://doi.org/10.1183/13993003.congress-2022.36200903-1936RIS: urn:DA3F8D460BB448BB40708E18DF4AEEDDRIS: urn:DA3F8D460BB448BB40708E18DF4AEEDDhttps://hdl.handle.net/2164/223011163872engR MedicineRDupilumab reduces OCS use and improves lung function in patients with severe OCS-dependent asthmaJournal item10.1183/13993003.congress-2022.3620http://erj.ersjournals.com/content/60/suppl_66/3620.abstract60